NEW YORK (Reuters Health) – Long-term treatment with fenofibrate does not seem to reduce atherosclerosis, inflammation or endothelial dysfunction in patients with type 2 diabetes, according to a…
NEW YORK (Reuters Health) – In a prospective study of adult patients at Massachusetts General Hospital in Boston, nearly one in five had elevated glycosylated hemoglobin A (HbA1c)…
NEW YORK (Reuters Health) – Women younger than 65 with diabetes tend to have worse cardiovascular risk profiles than diabetic men of the same age, leading to higher…
NEW YORK (Reuters Health) – New research shows that among the cognitive abilities that are affected by type 2 diabetes, processing speed appears to be the most severely…
NEW YORK (Reuters Health) – Symptoms of posttraumatic stress disorder (PTSD) appear to increase the long-term mortality rate in patients with implantable cardioverter defibrillators (ICDs), according to a…
NEW YORK (Reuters Health) – In patients with unstable type 1 diabetes, hypoglycemia awareness — which often deteriorates over time — can be enhanced with islet transplantation, new…
NEW YORK (Reuters Health) – Once elderly patients are diagnosed with Alzheimer’s disease, ethnicity and comorbidity appear to affect survival, investigators report in the November 4 issue of…
Dr. Robin Felder, PhD, Professor and Associate Director of Clinical Chemistry and Toxicology at the University of Virginia Health System, talks about the latest developments in regenerative medicine…
NEW YORK (Reuters Health) – If aspirin is to be used routinely for primary prevention of cardiovascular disease, it should begin at age 48 in men and 57…
NEW YORK (Reuters Health) – Nephropathy associated with iodinated contrast medium exposure can be fatal, physicians report in the October issue of Mayo Clinic Proceedings. However, the mortality…